Vistagen Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Vistagen Therapeutics Inc.
- Former names
- Excaliber Enterprises, Ltd.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- South SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- March
- Ticker symbol
- VTGN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001411685
- EIN
- 20-5093315
Board of directors
-
Ann Michelle Cunningham · DirectorSince 2024
-
Douglas J. Williamson · DirectorSince 2026
-
Jerry B. Gin · DirectorSince 2024
-
Joanne Curley · DirectorSince 2024
-
Jon S. Saxe · DirectorSince 2024
-
Margaret M. FitzPatrick · DirectorSince 2024
-
Mary L. Rotunno · DirectorSince 2024
-
Paul R. Edick · DirectorSince 2025
-
Shawn Singh · Director · President and CEOSince 2023
Chief executives
Shawn Singh
· President and CEO
Dates unknown
Director election results
Annual meeting of August 26, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
80.2%
-
87.0%
-
87.1%
-
94.8%
-
99.0%
Board connections
3 of this board's directors also sit on 3 other boards.
- via Margaret M. FitzPatrick
- via Ann Michelle Cunningham
- via Paul R. Edick
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Adler Reid G. Officer (Chief Legal Officer) | Grant or award | +36,818 | $0.19 | $7,073 |
| Jun 30, 2026 | Shawn Singh Director, Officer (President and CEO) | Grant or award | +36,818 | $0.19 | $7,073 |
| Jun 30, 2026 | Tressler Nick B. Officer (Chief Financial Officer) | Grant or award | +11,712 | $0.19 | $2,250 |
| Dec 31, 2025 | Prince Joshua S. Officer (Chief Operating Officer) | Grant or award | +4,386 | $0.56 | $2,456 |
| Jun 30, 2025 | Prince Joshua S. Officer (Chief Operating Officer) | Grant or award | +4,882 | $1.70 | $8,299 |
| Jun 30, 2025 | Adler Reid G. Officer (Chief Legal Officer) | Grant or award | +7,541 | $1.70 | $12,820 |
| Jun 30, 2025 | Anderson Cynthia Lynn Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +6,617 | $1.70 | $11,249 |
| Jun 30, 2025 | Shawn Singh Director, Officer (President and CEO) | Grant or award | +7,541 | $1.70 | $12,820 |
| Dec 31, 2024 | Prince Joshua S. Officer (Chief Operating Officer) | Grant or award | +3,310 | $2.51 | $8,308 |
| Dec 31, 2024 | Anderson Cynthia Lynn Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +2,592 | $2.51 | $6,506 |
| Jun 28, 2024 | Prince Joshua S. Officer (Chief Operating Officer) | Grant or award | +2,671 | $2.96 | $7,906 |
| Jun 28, 2024 | Anderson Cynthia Lynn Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +3,592 | $2.96 | $10,632 |
| Jun 28, 2024 | Adler Reid G. Officer (CHF CORP DEVEL OFF, GEN COUNS) | Grant or award | +4,854 | $2.96 | $14,368 |
| Jun 28, 2024 | Shawn Singh Director, Officer (CHIEF EXECUTIVE OFFICER) | Grant or award | +4,854 | $2.96 | $14,368 |
| Dec 29, 2023 | Adler Reid G. Officer (CHF CORP DEVEL OFF, GEN COUNS) | Grant or award | +167 | $1.72 | $287 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.